학술논문

The chemotherapeutic drug doxorubicin does not exacerbate p16Ink4a-positive senescent cell accumulation and cardiometabolic disease development in young adult female LDLR-deficient mice
Document Type
Article
Source
In: Toxicology and Applied Pharmacology. (Toxicology and Applied Pharmacology, 1 June 2023, 468)
Subject
Language
English
ISSN
10960333
0041008X